iCAD, Inc. (ICAD) Sharpe Ratio

Sharpe ratio is not yet available for ICAD. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.

How it compares to other similar stocks

The table compares iCAD, Inc.'s Sharpe Ratio with other stocks in the Health Information Services industry across multiple time periods, showing how ICAD's risk-adjusted performance compares to industry peers.

Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jun 3, 2026.

Symbol	Name	1Y Sharpe Ratio
BTSGU	BrightSpring Health Services Inc. Tangible Equity Unit	3.74
BTSG	BrightSpring Health Services, Inc	3.69
TXG	10x Genomics, Inc.	3.39
SY	So-Young International Inc.	1.21
SOPH	SOPHiA GENETICS SA	1.04
OMCL	Omnicell, Inc.	0.83
CRVW	Careview Comm Inc	0.75
HNGE	Hinge Health, Inc	0.70
PIAHY	Ping An Healthcare and Technology Company Limited	0.50
AMWL	American Well Corporation	0.45
ICAD	iCAD, Inc.	—

Benchmark Against

Benchmark

S&P 500 Index

Lookback Period

How to choose period

Historical Sharpe Ratio

The chart shows ICAD's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when ICAD consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.

Loading charts...

Sharpe Ratio Calculator

How does ICAD fit in your portfolio?

Add your other holdings to see your portfolio's Sharpe Ratio and find out.

Analyze Your Portfolio